VitroScreen offers innovative and robust in vitro research solutions from drug discovery to pre-clinical studies, providing scientific knowledge and high quality biological models, endpoints and protocols. VitroScreen takes a GLP-like approach to research projects and offers also full time equivalent research options. VitroScreen team has an unique expertise on the development and use of 3D human reconstituted living tissues (Epidermis, Skin, Cornea, Conjunctiva, Oral Mucosa, Vaginal Mucosa, Nasal and Bronchial Epithelia, Intestinal Epithelium, Bladder Epithelium) and micro-tissues (Cartilage, Bone, Fat, Liver, Tumors). VitroScreen experimental models are "mechanism based" and represent the most innovative and predictive approach for in vitro Safety and Efficacy testing.
Therapeutic areas: - dermatology and photo-dermatology and side effects on body barriers,
- ophthalmology,
- respiratory,
- mucosae and gastrointestinal tract,
- gynaecology,
- inflammation,
- wound healing,
- bio-adhesion:film forming, binding properties applied to bacteria and probiotics.
VitroScreen has competence and experience to identify the best testing strategy for Medical Devices according to regulatory classification, product type and target organ, offering in vitro testing solutions for assessing cytotoxicity, biocompatibility, irritation, sensitization potential, tissue penetration and a wide number of experimental models for Efficacy. Flexible partner, open to challenges for the development of tailor-made "omics" research protocols for tissue- and therapy-specific tasks in new generation pharmaceutical discovery and product development. | 
